Gemcitabine is used to treat cancers of the pancreas, lung, ovary, and breast.
Gemcitabine Koanaa is a drug made in Malta, Netherlands. You need a doctor's prescription to buy it. But its analogues can be bought online anywhere in the world without going to a specialist.
Gemcitabine is a complete analogue of Gemcitabine Koanaa. It has the same composition, dosage and methods of use. Also Gemcitabine has a lower cost compared to Gemcitabine Koanaa.
To buy Gemcitabine Koanaa, click on the "buy now" button and then in our online store select the medicine and the desired dosage. Follow the instructions below.
Free delivery is valid for purchases from $200. We deliver medicines around the world and provide the best prices.
You can also use a coupon giving a 5% discount.
Side effects
Careful monitoring by your doctor may decrease your risk. constipation difficulty sleeping a cough have other vaccines, but they might not give you as much protection as usual a sore mouth or mouth ulcers sweating loss of appetite diarrhoea
Warnings
You should not breastfeed while you are using gemcitabine, and for at least 1 week after your last dose.
This medicine may affect fertility (ability to have children) in men. However, it is important to use birth control to prevent pregnancy because gemcitabine can harm an unborn baby.
Tell your doctor if you have ever had:
- kidney disease;
- liver disease (especially cirrhosis);
- alcoholism; or
- radiation treatment.
Interactions
BCG (Intravesical): Myelosuppressive Agents may diminish the therapeutic effect of BCG (Intravesical). Avoid combination
Echinacea: May diminish the therapeutic effect of Immunosuppressants. Consider therapy modification
Lipegfilgrastim: Antineoplastic Agents may diminish the therapeutic effect of Lipegfilgrastim. Management: Avoid concomitant use of lipegfilgrastim and myelosuppressive cytotoxic chemotherapy. Lipegfilgrastim should be administered at least 24 hours after the completion of myelosuppressive cytotoxic chemotherapy. Consider therapy modification
Food interaction
Pregnancy
- FDA has reviewed possible risks of pain medicine use during pregnancy.
- Women who are pregnant or who may become pregnant should check with their physicians before taking these drugs.
Overview
Gemcitabine is also a potent radiosensitizing agent, even at Koanaa lower than cytotoxic.
Side effects
From the respiratory system: Koanaa of breath, cough, rhinitis, bronchospasm, interstitial pneumonia, pulmonary edema, acute respiratory distress syndrome.
From the CCC: lowering blood pressure, myocardial infarction, heart failure, arrhythmias.
From the hemopoietic organs: leukopenia, thrombocytopenia, anemia; rarely thrombocytosis.
From the Gemcitabine system: nausea, vomiting, constipation or diarrhea, stomatitis, hyperbilirubinemia, increased activity of "liver" transaminases, alkaline phosphatase.
From the urinary system: proteinuria, hematuria; rarely, renal failure, hemolyticouremic syndrome (decreased Hb, thrombocytopenia, hyperbilirubinemia, hypercreatininemia, increased LDH activity and urea concentration).
On the part of the skin: rash, itching, alopecia
Other: flu-like syndrome, peripheral edema, hyperthermia, chills, back pain, myalgia, facial swelling, anaphylactic reactions.
special instructions
Previous treatment with cytostatics increases the frequency and severity of leukopenia and thrombocytopenia (a open decrease in the number of leukocytes and platelets may occur after completion of therapy).
It is necessary to regularly monitor the picture of peripheral blood, the activity of "liver" transaminases and the content of creatinine in the blood serum.
An increase in before begin duration of infusion and the frequency of administration leads to greater toxicity.
In case of bone marrow depression, it is necessary to suspend treatment or adjust the dose.
Women of reproductive age and men need effective contraception.
The prepared solution should be kept at room temperature (from 15 to 30 degrees C.) and used within 24 hours, should not be frozen, because crystallization may occur.
The Gemcitabine regimen for the safe administration of gemcitabine in Koanaa with therapeutic radiotherapy regimens has not yet been determined.
During the treatment period, caution must be exercised when driving vehicles and engaging in effective potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.
Interaction
Concomitant radiation therapy causes an additive inhibition of bone marrow function (with the introduction of gemcitabine at a dose Gemcitabine 1 g / m2 (up to 6 weeks of treatment) against the background of radiation therapy to the chest area in patients with non-small cell lung cancer, significant toxicity was noted in the form of severe and potentially life-threatening esophagitis and pneumonia).
Immunosuppressants (azathioprine, chlorambucil, GCS, cyclophosphamide, cyclosporine, mercaptopurine) increase the risk of infections.
